Quest Diagnostics (DGX) EPS (Diluted) Growth (3y) (2012 - 2026)
Quest Diagnostics (DGX) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.87% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 293.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.87% |
| Mar 31, 2026 | 7.36% |
| Dec 31, 2025 | 32.02% |
| Sep 30, 2025 | -0.98% |
| Jun 30, 2025 | 7.10% |
| Mar 31, 2025 | -12.09% |
| Dec 31, 2024 | -12.31% |
| Sep 30, 2024 | -20.10% |
| Jun 30, 2024 | -29.05% |
| Mar 31, 2024 | -20.12% |
| Jun 30, 2022 | 141.34% |
| Dec 31, 2017 | 276.18% |
| Dec 31, 2014 | 1.52% |
| Sep 30, 2013 | 103.41% |
| Jun 30, 2013 | 290.05% |
| Mar 31, 2013 | 34.63% |
| Dec 31, 2012 | -695.19% |
| Sep 30, 2012 | 120.52% |
| Jun 30, 2012 | 198.51% |
| Mar 31, 2012 | 26.04% |